$DUKR
Stock $dukr

$dukr Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000121390022045057 Filed on August 05, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q4
Revenue			$0.00
YoY Change
Cost Of Revenue			$0.00
YoY Change
Gross Profit			$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$223.0K	$327.0K	$108.0K
YoY Change	-54.02%	20.66%	-43.46%
% of Gross Profit
Research & Development	$11.00K	$3.000K	$14.00K
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.000K	$1.000K	$1.000K
YoY Change	0.0%		0.0%
% of Gross Profit
Operating Expenses	$11.00K	$3.000K	$107.0K
YoY Change	-97.94%		-43.98%
Operating Profit	-$234.0K	-$330.0K	-$107.0K
YoY Change	-56.18%	21.77%	-43.98%
Interest Expense	-$4.000K	$43.00K	$173.0K
YoY Change	-98.42%	-129.25%	232.69%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$238.0K	-$287.0K	$66.00K
YoY Change	-69.76%	-31.34%	-147.48%
Income Tax
% Of Pretax Income
Net Earnings	-$238.0K	-$287.0K	$66.00K
YoY Change	-69.76%	-31.34%	-147.48%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.01
Diluted Earnings Per Share	$0.00	-$0.01	$1.221K
COMMON SHARES
Basic Shares Outstanding	54.22M shares	54.12M shares
Diluted Shares Outstanding		54.12M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.010M	$3.154M	$3.560M
YoY Change	-19.3%	-20.07%	3290.48%
Cash & Equivalents	$3.010M	$3.154M	$3.560M
Short-Term Investments
Other Short-Term Assets	$36.00K	$52.00K	$40.00K
YoY Change	-29.41%	-7.14%	110.53%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$3.046M	$3.206M	$3.600M
YoY Change	-19.44%	-19.89%	2803.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.00K	$23.00K	$9.000K
YoY Change	120.0%	109.09%	-25.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.00K	$15.00K
YoY Change
Total Long-Term Assets	$37.00K	$38.00K	$9.000K
YoY Change	270.0%	245.45%	-25.0%
TOTAL ASSETS
Total Short-Term Assets	$3.046M	$3.206M	$3.600M
Total Long-Term Assets	$37.00K	$38.00K	$9.000K
Total Assets	$3.083M	$3.244M	$3.609M
YoY Change	-18.68%	-19.16%	2553.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$87.00K	$77.00K	$75.00K
YoY Change	-12.12%	-38.4%	-76.71%
Accrued Expenses	$101.0K	$98.00K	$136.0K
YoY Change	4.12%	-38.36%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$188.0K	$175.0K	$211.0K
YoY Change	-64.05%	-38.38%	-83.77%
LONG-TERM LIABILITIES
Long-Term Debt	$303.0K	$301.0K	$297.0K
YoY Change	3.06%	2.73%	-54.93%
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$303.0K	$301.0K	$297.0K
YoY Change	3.06%	2.73%	-56.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$188.0K	$175.0K	$211.0K
Total Long-Term Liabilities	$303.0K	$301.0K	$297.0K
Total Liabilities	$491.0K	$476.0K	$508.0K
YoY Change	-39.9%	-17.5%	-74.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.913M	-$6.675M	-$6.019M
YoY Change
Common Stock	$5.000K	$5.000K	$5.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.592M	$2.768M	$3.101M
YoY Change
Total Liabilities & Shareholders Equity	$3.083M	$3.244M	$3.609M
YoY Change	-18.68%	-19.16%	2553.68%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q4
OPERATING ACTIVITIES
Net Income	-$238.0K	-$287.0K	$66.00K
YoY Change	-69.76%	-31.34%	-147.48%
Depreciation, Depletion And Amortization	$1.000K	$1.000K	$1.000K
YoY Change	0.0%		0.0%
Cash From Operating Activities	-$144.0K	-$243.0K	-$170.0K
YoY Change	-33.33%	20.9%	8.28%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$3.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$15.00K
YoY Change
Cash From Investing Activities	$0.00	-$18.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	0.000
YoY Change		-100.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-144.0K	-243.0K	-170.0K
Cash From Investing Activities	0.000	-18.00K
Cash From Financing Activities	0.000	0.000	0.000
Net Change In Cash	-144.0K	-261.0K	-170.0K
YoY Change	-33.33%	-107.47%	2.41%
FREE CASH FLOW
Cash From Operating Activities	-$144.0K	-$243.0K	-$170.0K
Capital Expenditures	$0.00	-$3.000K
Free Cash Flow	-$144.0K	-$240.0K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	usdr	Other Accounts Liabilities Current OtherAccountsLiabilitiesCurrent	98000	usd
CY2021Q4	usdr	Other Accounts Liabilities Current OtherAccountsLiabilitiesCurrent	136000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	175000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	211000	usd
CY2022Q2	usdr	Stockholders Loans Noncurrent StockholdersLoansNoncurrent	301000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55504
	dei	Entity Registrant Name EntityRegistrantName	UAS Drone Corp.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3052410
	dei	Entity Address Address Line1 EntityAddressAddressLine1	10 HaRimon Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Mevo Carmel Science and Industrial Park
	dei	Entity Address City Or Town EntityAddressCityOrTown	Israel
	dei	Entity Address Country EntityAddressCountry	IL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	2069203
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54218813	shares
CY2022Q2	us-gaap	Cash Cash	3154000	usd
CY2021Q4	us-gaap	Cash Cash	3560000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	52000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	3206000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	3600000	usd
CY2022Q2	us-gaap	Deferred Costs Leasing Net Noncurrent DeferredCostsLeasingNetNoncurrent	15000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9000	usd
CY2022Q2	us-gaap	Assets Assets	3244000	usd
CY2021Q4	us-gaap	Assets Assets	3609000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	77000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	75000	usd
CY2021Q4	usdr	Stockholders Loans Noncurrent StockholdersLoansNoncurrent	297000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	476000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	508000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54118813	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54118813	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54018813	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54018813	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9438000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9115000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6675000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6019000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2768000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3101000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3244000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3609000	usd
	us-gaap	Revenues Revenues	500000	usd
	us-gaap	Gross Profit GrossProfit	500000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	658000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	433000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	327000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	271000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	132000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-667000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	199000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-330000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-271000	usd
	usdr	Financing Incomeexpense Net FinancingIncomeexpenseNet	11000	usd
	usdr	Financing Incomeexpense Net FinancingIncomeexpenseNet	-366000	usd
CY2022Q2	usdr	Financing Incomeexpense Net FinancingIncomeexpenseNet	43000	usd
CY2021Q2	usdr	Financing Incomeexpense Net FinancingIncomeexpenseNet	-147000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-656000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-167000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-287000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-418000	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54076824	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44325572	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54118813	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48091085	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3101000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	180000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-369000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2912000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	143000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-287000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2768000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1849000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	345000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	38000	usd
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	251000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1215000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	361000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4605000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	103000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-418000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3436000	usd
	us-gaap	Profit Loss ProfitLoss	-656000	usd
	us-gaap	Profit Loss ProfitLoss	-167000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	323000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	141000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	4000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5000	usd
	usdr	Expenses With Respect To Changes In Fair Value Of Option Granted In Equity Financing ExpensesWithRespectToChangesInFairValueOfOptionGrantedInEquityFinancing	-326000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	12000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	37000	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	2000	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	16000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-38000	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-133000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-376000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	152000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	15000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4649000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	954000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3689000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-406000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3841000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3560000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3154000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3946000	usd
	us-gaap	Interest Paid Net InterestPaidNet	59000	usd
	usdr	Issuance Of Shares In Exchange For Convertible Loans IssuanceOfSharesInExchangeForConvertibleLoans	706000	usd
	us-gaap	Stock Issued1 StockIssued1	44000	usd
CY2020Q2	usdr	Common Stock Par Value Per Share CommonStockParValuePerShare	0.0001
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions relate to share based compensation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	usdr	Directors Compensation DirectorsCompensation	130000	usd
CY2021Q2	usdr	Directors Compensation DirectorsCompensation	52000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	104000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	84000	usd
CY2022Q1	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	300000	shares
CY2022Q1	usdr	Number Of Tranches NumberOfTranches	three
CY2022Q1	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	100000	shares
	usdr	Share Based Compensation Expense ShareBasedCompensationExpense	15000	usd
CY2021Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	12500000	shares
CY2022Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P18M
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.4
CY2022Q2	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	27000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2426812	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.81
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2426812	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.81
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	758680	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.81
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	84000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice	0.19
CY2022Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	41000	usd
CY2021Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	84000	usd
	us-gaap	Financing Interest Expense FinancingInterestExpense	4000	usd
	us-gaap	Financing Interest Expense FinancingInterestExpense	4000	usd
CY2022Q2	us-gaap	Financing Interest Expense FinancingInterestExpense	2000	usd
CY2022Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2426812	shares
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y8M8D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	758680	shares
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2426812	shares
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y9M10D
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	308000	usd
CY2021Q3	usdr	Issuance Options To Purchase Shares IssuanceOptionsToPurchaseShares	490000	shares
	usdr	Total Value Of Share Based Compensation TotalValueOfShareBasedCompensation	62000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y
CY2022Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P2Y
	us-gaap	Lease Cost LeaseCost	5200	usd
CY2022Q2	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.05	pure
CY2022Q2	us-gaap	Other Commitment OtherCommitment	15	usd
	usdr	Directors Compensation DirectorsCompensation	282000	usd
	usdr	Directors Compensation DirectorsCompensation	106000	usd
CY2021Q2	us-gaap	Financing Interest Expense FinancingInterestExpense	2000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	25000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	30000	usd
CY2022Q2	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	279000	usd
CY2021Q4	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	276000	usd
CY2021Q1	usdr	Description Of Board Of Directors DescriptionOfBoardOfDirectors	the Board of Directors appointed Yossi Balucka to serve as its Chief Executive Officer. Mr. Balucka is entitled to a monthly fee of NIS30,000 (approximately $9,650), reimbursement of expenses and discretionary performance bonus. In conjunction with the appointment of Mr. Balucka, the Company issued to Mr. Balucka options to purchase 450,000 shares of the Company’s commons stock at an exercise price of $0.0001 per share, subject to and in accordance with the terms and conditions of an Option Plan.
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	usdr	Expenses With Respect To Changes In Fair Value Of Option Granted In Equity Financing ExpensesWithRespectToChangesInFairValueOfOptionGrantedInEquityFinancing		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	usdr	Issuance Of Shares In Exchange For Convertible Loans IssuanceOfSharesInExchangeForConvertibleLoans		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	usdr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercise In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExerciseInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2021Q4	usdr	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRange
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares		shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001638911

Files In Submission

Name	View Source	Status
0001213900-22-045057-index-headers.html	Edgar Link	pending
0001213900-22-045057-index.html	Edgar Link	pending
0001213900-22-045057.txt	Edgar Link	pending
0001213900-22-045057-xbrl.zip	Edgar Link	pending
f10q0622ex31-1_uasdrone.htm	Edgar Link	pending
f10q0622ex31-2_uasdrone.htm	Edgar Link	pending
f10q0622ex32-1_uasdrone.htm	Edgar Link	pending
f10q0622ex32-2_uasdrone.htm	Edgar Link	pending
f10q0622_uasdrone.htm	Edgar Link	pending
f10q0622_uasdrone_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
usdr-20220630.xsd	Edgar Link	pending
usdr-20220630_cal.xml	Edgar Link	unprocessable
usdr-20220630_def.xml	Edgar Link	unprocessable
usdr-20220630_lab.xml	Edgar Link	unprocessable
usdr-20220630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DUKR
Stock $dukr

2022 Q3 Form 10-Q Financial Statement

#000121390022045057 Filed on August 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DUKR Stock $dukr

2022 Q3 Form 10-Q Financial Statement

#000121390022045057 Filed on August 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DUKR
Stock $dukr